Ligamax LGD-3033

LGD-3033 is a novel 3rd-gen SARM representing the next iteration in the LGD series by Ligand Pharmaceuticals. Building upon the anabolic foundation of its predecessor LGD-4033 Ligandrol, LGD-3033 is designed with enhanced tissue selectivity and a more favorable anabolic-to-androgenic ratio. 

Its precise chemical structure modifications aim to deliver even more potent muscle-building and strength-enhancing effects while further minimizing unwanted androgenic side effects such as those impacting the prostate, skin, and hair follicles. 

As a third-generation SARM, it pushes the boundaries of targeted anabolic enhancement for researchers focused on maximizing lean mass accrual.

LGD-3033 Benefits

LGD-3033 is engineered for users seeking the upper limits of SARM-induced hypertrophy and strength, with a refined side effect profile.

Lean Muscle Mass Accretion

Preliminary research and user data suggest LGD-3033 possesses superior anabolic potency compared to earlier SARMs. It promotes rapid and substantial gains in lean body mass, making it a candidate for advanced bulking cycles where maximum size is the primary goal.

Increase in Strength

The compound’s strong binding affinity translates directly to the weight room. Users report swift and significant improvements in one-rep maximums and the ability to handle heavier training volumes, driving a potent cycle of progressive overload.

Muscle Fullness and Density

Ligamax promotes significant intracellular hydration and glycogen retention within muscle tissue, leading to a pronounced “full,” hard, and dense appearance. Muscle bellies appear rounder and more vascular even at rest.

Improved Androgenic Selectivity

As a newer generation compound, its molecular design specifically aims to reduce activation of androgen receptors in non-target tissues. The goal is to significantly lower the risk of androgenic alopecia (hair loss) and severe acne compared to both traditional steroids and earlier SARMs.

LGD-3033 Side Effects

While designed for improved selectivity, LGD-3033 remains a potent androgen receptor agonist with a significant hormonal impact.

Testosterone Suppression

Like all strong SARMs, LGD-3033 is expected to be highly suppressive to natural testosterone production. The degree of suppression is likely dose-dependent and could be significant, necessitating a mandatory and well-planned Post-Cycle Therapy (PCT) protocol.

Estrogenic Side Effects

Although non-aromatizing, the suppression of testosterone can create a state of relative estrogen dominance. This imbalance can potentially lead to estrogenic side effects such as gynecomastia (development of breast tissue) and water retention in susceptible individuals, requiring careful monitoring and possibly the use of an Aromatase Inhibitor (AI).

Negative Impact on Cardiovascular Markers

A strong anabolic effect often comes at a cost to lipid profiles. LGD-3033 is anticipated to significantly suppress HDL (“good”) cholesterol and may elevate LDL, increasing long-term cardiovascular strain. Lipid management support is crucial.

Hepatotoxic Potential

While not as liver-toxic as 17-alpha-alkylated orals, any oral compound processed by the liver can cause enzyme elevations (ALT/AST). Liver support supplements are a non-negotiable component of a responsible cycle.

Water Retention and Blood Pressure

Significant intracellular and extracellular fluid retention is common, leading to a “puffy” look and potential increases in blood pressure. Managing sodium intake is important.

How to Take LGD-3033 Ligamax

Given its advanced and potent nature, a conservative and disciplined approach is paramount.

LGD-3033 Cycle Length

Given its potency, cycle length should be strictly controlled. A cycle of 6 to 8 weeks is recommended to manage suppression and side effect accumulation. Longer cycles are not advised for initial use.

LGD-3033 Dosage for Men

An effective yet conservative dosing range is estimated to be 5 mg to 15 mg per day, taken orally. It is strongly advised to start at the absolute lowest end (5 mg) to assess individual response.

Dosage for Women

Not recommended. Due to its high anabolic potency and androgenic potential, the risk of virilization (voice deepening, clitoral enlargement) is considered extreme. Safer alternatives exist for female researchers.

Best Stacks with LGD-3033

LGD-3033 is a foundational bulking agent that stacks with compounds offering complementary benefits.

The Ultimate Mass Stack

LGD-3033 and MK-677 (Ibutamoren) stack. This stack aims for maximum size. LGD-3033 provides the direct anabolic stimulus, while MK-677 elevates Growth Hormone and IGF-1, dramatically improving deep sleep, recovery, and appetite—creating the perfect internal environment for growth.

The Strength & Density Stack

LGD-3033 and RAD-140 (Testolone) stack. This is an extremely potent and advanced stack combining two of the strongest SARMs for the sole purpose of achieving dramatic increases in lean mass, density, and strength. It places immense strain on the body’s systems and should only be considered with extensive experience and comprehensive health monitoring.

The Quality Mass Stack

LGD-3033 and Cardarine (GW-501516) stack. For a leaner bulk, adding Cardarine can help manage fat gain, improve endurance for high-volume training, and support cardiovascular health markers that may be negatively impacted by LGD-3033.

LGD-3033 (Ligamax) Cycle Guidelines

This table outlines a prudent 8-week theoretical protocol for an experienced male researcher. Begin all support supplements (liver, heart) on day one.

Results to Expect with LGD-3033 aka Ligamax

As a next-generation compound, expectations are for pronounced anabolic effects.
Users can anticipate rapid and substantial gains in lean mass, potentially exceeding the results seen with LGD-4033 over a similar timeframe. 

Strength increases should be significant and quick, allowing for consistent progression in lifting numbers. The physique should develop a thick, full, and dense appearance with noticeable vascularity.

A portion of initial weight will be water, but a disciplined post-cycle protocol will help solidify quality muscle tissue. Results are entirely dependent on a significant caloric surplus and intense, progressive training.

Compliance and Security

• Ligamax is an unapproved new drug under Canada’s Food and Drugs Act. You can get LGD-3033 for sale at NEO SARMs only as a research compound in 10mg tablets.
• It is not listed as a controlled substance on the Controlled Drugs and Substances Act (CDSA). Simple personal possession is not a criminal drug offense.
• As a SARM, it falls under the WADA prohibition of all selective androgen receptor modulators and is banned in all tested sports.